MDA Space Ltd. MDA
—
31.49
0.01
0.03%
as of 25 Sep
- Market cap
- $5.2B
- P/E
- 53.6×
Follow MDA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+3 more quarters Free account |
49.29 | 49.29 | 41.68 | 70.23 |
P/S ratio |
3.27 | 3.27 | 2.57 | 4.24 | |
P/FCF ratio |
40.42 | 40.42 | 0.00 | 0.00 | |
P/Operating CF |
107.21 | 107.21 | 73.22 | (84.45) | |
P/B ratio |
3.95 | 3.95 | 2.41 | 4.20 | |
Price to Tangible BV |
0.00 | 0.00 | 26.37 | 38.67 | |
EV/Sales |
3.42 | 3.42 | 2.47 | 4.22 | |
EV/EBITDA |
19.59 | 19.59 | 13.89 | 24.76 | |
EV/Operating CF |
13.71 | 13.71 | 20.76 | 154.33 | |
EV/FCF |
42.22 | 42.22 | (45.47) | (32.64) | |
Quick Ratio |
0.49 | 0.41 | 0.73 | 0.69 | |
Current Ratio |
0.55 | 0.47 | 0.80 | 0.75 | |
Net Debt/EBITDA |
2.92 | 2.75 | (2.22) | (0.51) | |
Debt/Assets |
11.81% | 11.65% | 9.51% | 9.54% | |
Debt/Equity |
0.31 | 0.29 | 0.20 | 0.19 | |
Asset Turnover |
— | 0.54 | 0.53 | 0.54 | |
Operating CF/Net income |
1.40 | 2.06 | 2.06 | (3.37) | |
Capex/Depreciation |
(1.72) | (1.74) | (2.08) | (1.40) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.90% | 2.93% | 1.85% | 2.61% | |
Selling, General and Administrative Expense of Revenue |
8.08% | 7.06% | 7.76% | 10.37% | |
Intangible Assets out of Total Assets |
0.48 | 0.50 | 0.44 | 0.45 | |
Share Based Compensation of Revenue |
0.98% | 0.67% | 0.93% | 1.10% | |
Graham Net Nets |
(0.26) | (0.26) | (0.20) | (0.12) | |
Graham Number |
0.00 | 10.48 | 11.97 | 11.41 | |
Earnings Yield |
2.03% | 2.03% | 2.40% | 1.42% | |
Free Cash Flow Yield |
2.47% | 2.47% | (2.11%) | (3.05%) | |
Revenue per Share |
2.37 | 2.87 | 2.64 | 2.59 | |
Operating CF per Share |
0.20 | 0.29 | 0.35 | (0.49) | |
Capex per Share |
(0.41) | (0.41) | (0.50) | (0.33) | |
Free Cash Flow per Share |
(0.21) | (0.12) | (0.16) | (0.81) | |
Cash per Share |
1.13 | 0.88 | 3.09 | 2.07 | |
Shareholders Equity per Share |
7.69 | 7.81 | 10.49 | 9.84 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.69 | 7.81 | 10.49 | 9.84 | |
Free Cash Flow |
(26.09) | (15.50) | (20.12) | (113.00) | |
Working Capital |
(461.16) | (503.35) | (195.35) | (222.47) | |
Capital Expenditures |
(50.83) | (51.20) | (64.51) | (45.14) | |
Net Current Asset Value |
(987.95) | (992.46) | (662.64) | (685.75) | |
EV/EBIT |
35.40 | 35.40 | 26.51 | 52.73 | |
Capex to Sales |
0.17 | 0.14 | 0.19 | 0.13 | |
Net Profit Margin |
5.95% | 4.86% | 6.38% | 5.60% | |
Price to Operating Income |
33.88 | 33.88 | 27.64 | 52.99 | |
| Other line items | |||||
Average Receivables |
— | 276.68 | 286.66 | 297.90 | |
Average Payables |
— | 230.81 | 265.99 | 309.72 | |
Average Inventory |
— | 11.37 | 17.80 | 16.47 | |
Average Assets |
— | 2,148.84 | 2,376.21 | 2,501.56 | |
Average Common Equity |
— | 914.01 | 1,096.16 | 1,146.34 |
Columns are period end dates